WallStreetZenWallStreetZen

NYSEMKT: VTAK
Catheter Precision Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Catheter Precision earnings were -$22.2M for the trailing 12 months ending Sep 30, 2025, with 97.9% growth year over year. The latest VTAK earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$5.8M, up 156.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VTAK reported annual earnings of -$17.2M, with -21.2% growth.

VTAK past earnings growth

How has VTAK's earnings growth performed historically?

Company
97.86%
Industry
23.12%
Market
86.43%
VTAK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
VTAK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
VTAK's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

VTAK earnings history

Current Revenue
$819.0k
Current Earnings
-$17.2M
Current Profit Margin
-2,098%

VTAK Return on Equity

Current Company
-240.8%
Current Industry
8.8%
Current Market
28.9%
VTAK's Return on Equity (-267%)... subscribe to Premium to read more.
High Return on Equity Performance

VTAK Return on Assets

Current Company
-75%
Current Industry
5.4%
VTAK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VTAK announces earnings.

VTAK Return on Capital Employed

Current Company
-156.55%
Current Industry
9.4%
VTAK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VTAK vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VTAK-$13.12M-$22.19M+97.86%$33.30
BJDX-$6.68M-$6.85MN/A-$15.25
BBLG-$3.11M-$3.11MN/A-$2.65
IVF-$27.33M-$29.21MN/A-$3,327.80
NUWE-$6.55M-$17.52MN/A-$25.39
View Top Medical Device Stocks

Catheter Precision Earnings Reports & History FAQ

What were Catheter Precision's earnings last quarter?

Catheter Precision (NYSEMKT: VTAK) reported Q4 2025 earnings per share (EPS) of -$2.88, up 105.83% year over year. Total VTAK earnings for the quarter were -$5.78 million. In the same quarter last year, Catheter Precision's earnings per share (EPS) was $49.36.

If you're new to stock investing, here's how to buy Catheter Precision stock.

Is Catheter Precision profitable or losing money?

As of the last Catheter Precision earnings report, Catheter Precision is currently losing money. Catheter Precision's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$17.18 million, a 3.24% increase year over year.

What was VTAK's earnings growth in the past year?

As of Catheter Precision's earnings date in Q2 2026, Catheter Precision's earnings has grown 97.86% year over year. This is 74.74 percentage points higher than the US Medical Devices industry earnings growth rate of 23.12%. VTAK earnings in the past year totalled -$22.19 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.